Trade Sana Biotechnology, Inc. - SANA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.14 |
| Open | 3.01 |
| 1-Year Change | -39.92% |
| Day's Range | 2.89 - 3.21 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 2.89 | -0.23 | -7.37% | 3.12 | 3.25 | 2.88 |
| Jan 17, 2025 | 3.13 | -0.03 | -0.95% | 3.16 | 3.35 | 3.12 |
| Jan 16, 2025 | 3.23 | -0.56 | -14.78% | 3.79 | 3.79 | 3.03 |
| Jan 15, 2025 | 3.83 | 0.23 | 6.39% | 3.60 | 3.83 | 3.17 |
| Jan 14, 2025 | 3.60 | 0.19 | 5.57% | 3.41 | 3.77 | 3.18 |
| Jan 13, 2025 | 3.44 | -0.20 | -5.49% | 3.64 | 3.99 | 3.17 |
| Jan 10, 2025 | 3.63 | -1.38 | -27.54% | 5.01 | 5.12 | 3.53 |
| Jan 8, 2025 | 4.27 | -1.98 | -31.68% | 6.25 | 7.26 | 4.10 |
| Jan 7, 2025 | 1.63 | -0.11 | -6.32% | 1.74 | 1.88 | 1.62 |
| Jan 6, 2025 | 1.71 | 0.02 | 1.18% | 1.69 | 1.81 | 1.66 |
| Jan 3, 2025 | 1.68 | 0.03 | 1.82% | 1.65 | 1.74 | 1.64 |
| Jan 2, 2025 | 1.63 | 0.02 | 1.24% | 1.61 | 1.74 | 1.59 |
| Dec 31, 2024 | 1.61 | 0.03 | 1.90% | 1.58 | 1.62 | 1.52 |
| Dec 30, 2024 | 1.59 | 0.00 | 0.00% | 1.59 | 1.61 | 1.50 |
| Dec 27, 2024 | 1.59 | 0.00 | 0.00% | 1.59 | 1.67 | 1.53 |
| Dec 26, 2024 | 1.67 | 0.01 | 0.60% | 1.66 | 1.72 | 1.60 |
| Dec 24, 2024 | 1.73 | 0.11 | 6.79% | 1.62 | 1.74 | 1.62 |
| Dec 23, 2024 | 1.60 | 0.02 | 1.27% | 1.58 | 1.62 | 1.54 |
| Dec 20, 2024 | 1.63 | 0.07 | 4.49% | 1.56 | 1.69 | 1.54 |
| Dec 19, 2024 | 1.58 | -0.07 | -4.24% | 1.65 | 1.65 | 1.53 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Sana Biotechnology, Inc. Company profile
About Sana Biotechnology Inc
Sana Biotechnology, Inc is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing and controlling genes in the body, referred to as gene therapy or in vivo cell engineering, requires in vivo delivery of a therapeutic payload and modification of the genome. The Company’s fusogen technology in preclinical studies targets cell surface receptors when combined with delivery vehicles to form fusosomes and allows cell-specific delivery across multiple different cell types. It focuses this technology on delivering payloads to T cells, hepatocytes, and hematopoietic stem cells (HSCs).
Financial summary
BRIEF: For the nine months ended 30 September 2021, Sana Biotechnology Inc revenues was not reported. Net loss increased 42% to $245.2M. Higher net loss reflects Personnel increase of 36% to $55.2M (expense), General and administrative - Balancing increase of 80% to $32.6M (expense), Stock-based Compensation in R&D increase from $2.6M to $9.9M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
188 East Blaine Street, Suite 400
SEATTLE
WASHINGTON 98102
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com